Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. (Q37421286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308035%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

review article

1 reference

title

Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308035%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308035%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

A Tyndall

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308035%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

English

0 references

publication date

23 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308035%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308035%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308035%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308035%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

821-828

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19308035%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2009.63

24 January 2020

exact match

0 references

cites work

Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

Treatment of stroke in rat with intracarotid administration of marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

Mesenchymal stem cells: paradoxes of passaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Characterization of cells with osteogenic potential from human marrow

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Marrow stromal cells as stem cells for nonhematopoietic tissues

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stromal cells from umbilical cord blood

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Isolation and characterization of mesenchymal cells from human fetal membranes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Stem cells and rheumatology: update on adult stem cell therapy in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Immunoregulatory function of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

"Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Immunomodulatory effects of fetal and adult mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Human mesenchymal stem cells modulate B-cell functions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Human mesenchymal stem cells promote survival of T cells in a quiescent state.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells stimulate antibody secretion in human B cells.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells induce apoptosis of activated T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Recent advances into the understanding of mesenchymal stem cell trafficking

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells as trophic mediators

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Insulin-Like Growth Factor-1 Sustains Stem Cell Mediated Renal Repair

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Neural stem cell-mediated immunomodulation: repairing the haemorrhagic brain

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Sarcoma derived from cultured mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021

A new cell therapy registry coordinated by the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.63

7 January 2021